The elevated expression of SLC14A1, phospho-Smad2, and Snail not only corroborates their synergistic interaction but also underscores their potential as significant biomarkers and therapeutic targets for managing CRC progression and metastasis. This evidence concerns the gene SNAI1 and colorectal carcinoma.